KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $446.32.

  • Novartis Ag's EPS (Basic) fell 1956.65% to $446.32 in Q4 2025 from the same period last year, while for Dec 2025 it was $446.32, marking a year-over-year decrease of 1956.65%. This contributed to the annual value of $1939.5 for FY2025, which is 384.38% down from last year.
  • Per Novartis Ag's latest filing, its EPS (Basic) stood at $446.32 for Q4 2025, which was down 1956.65% from $0.0 recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's EPS (Basic) peaked at $2388.5 during Q1 2024, and registered a low of $0.0 during Q1 2021.
  • Moreover, its 5-year median value for EPS (Basic) was $100.73 (2022), whereas its average is $534.38.
  • As far as peak fluctuations go, Novartis Ag's EPS (Basic) crashed by 10000.0% in 2021, and later soared by 7380738739713.97% in 2022.
  • Quarter analysis of 5 years shows Novartis Ag's EPS (Basic) stood at $0.0 in 2021, then skyrocketed by 721325138.36% to $54.51 in 2022, then skyrocketed by 2494.86% to $1414.5 in 2023, then tumbled by 60.77% to $554.9 in 2024, then decreased by 19.57% to $446.32 in 2025.
  • Its EPS (Basic) stands at $446.32 for Q4 2025, versus $0.0 for Q3 2025 and $0.0 for Q2 2025.